FDA Adverse Event Death Summary report: N

ENDURANT

MDR report key: 3132751 · Received May 29, 2013

Report

Report Number
2953200-2013-01016
Event Type
Death
Date Received
May 29, 2013
Date of Event
April 23, 2013
Report Date
May 1, 2013
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION, RESULTS: INHERENT RISK OF PROCEDURE (OCCLUSION, DEATH, RENAL FAILURE, ENDOLEAK, EMBOLISM); PATIENT'S CONDITION AFFECTED EFFECTIVENESS OF DEVICE (ANATOMY RELATED; TYPE II ENDOLEAK, RENAL FAILURE); (INSUFFICIENT INFORMATION; CAUSE OF THE THROMBUS WITHIN THE STENT GRAFT IS UNKNOWN). CONCLUSION: DEVICE FAILURE/LACK OF EFFECTIVENESS RELATED TO PATIENT CONDITION (ANATOMY RELATED; TYPE II ENDOLEAK, RENAL FAILURE); KNOWN INHERENT RISK OF A PROCEDURE (OCCLUSION, DEATH, RENAL FAILURE, ENDOLEAK, EMBOLISM); (INSUFFICIENT INFORMATION; CAUSE OF THE THROMBUS WITHIN THE STENT GRAFT IS UNKNOWN).

Description of Event or Problem · 1

AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN 8.6 CM DIAMETER ABDOMINAL AORTIC ANEURYSM. THE PROXIMAL AORTA WAS 31 MM IN DIAMETER AND 55 MM IN LENGTH. DISTAL AORTA WAS 27 MM IN DIAMETER. RIGHT ILIAC ARTERY WAS 15 MM IN DIAMETER AND THE LEFT ILIAC ARTERY WAS 13 MM IN DIAMETER. THE RIGHT AND LEFT FEMORAL ARTERIES WERE 10 MM IN DIAMETER. THE RIGHT AND LEFT ILIAC ARTERIES WERE MILDLY TORTUOUS. POST INDEX PROCEDURE, A TYPE II ENDOLEAK WAS NOTED AND WAS LEFT UNCORRECTED. IT WAS REPORTED THAT THE PATIENT WAS ADMITTED TO THE HOSPITAL. THE ANEURYSM WAS 89 MM IN DIAMETER. A TECHNICAL OBSERVATION WAS NOTED. THERE WAS MINIMAL THROMBUS PRESENT IN THE BODY OF THE STENT GRAFT; SPECULATION IS THAT THE PATIENT SUFFERED BILATERAL POPLITEAL ARTERY EMBOLI FROM THE SMALL DEGREE OF THROMBUS IN THE BODY OF THE STENT GRAFT. THE PATIENT HAD RENAL FAILURE RESULTING IN DEATH. BLOOD WORK WAS DONE AND CREATININE FOUND TO BE 465 UMOL/L. (PRE EVAR WAS 208). THIS IS LIKELY DUE TO LONG TERM CYCLOSPORINE USE. THE PATIENT DID NOT WISH TO RECEIVE ANY TREATMENT. THE INVESTIGATOR ASSESSMENT STATES THAT THE EVENT WAS NOT RELATED TO THE DEVICE OR PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
235025 ENDURANT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND V00508131

Patients

Seq Age Sex Outcome Treatment
1 00069 YR Death